36 related articles for article (PubMed ID: 15272532)
1. Computer-Assisted Annotation of Digital H&E/SOX10 Dual Stains Generates High-Performing Convolutional Neural Network for Calculating Tumor Burden in H&E-Stained Cutaneous Melanoma.
Nielsen PS; Georgsen JB; Vinding MS; Østergaard LR; Steiniche T
Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361209
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of CD117 in various cutaneous melanocytic lesions.
Radu A; Bejenaru C; Ţolea I; Maranduca MA; Brănişteanu DC; Bejenaru LE; Petrariu FD; Stoleriu G; Brănişteanu DE
Exp Ther Med; 2021 Jan; 21(1):78. PubMed ID: 33363589
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of UHRF1 promotes the progression of melanoma by inducing cell proliferation.
Wei C; Lu N; Wang L; Zhang Y; Feng Z; Yang Y; Qi F; Gu J
Oncol Rep; 2018 Jun; 39(6):2553-2562. PubMed ID: 29620240
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of C-kit protein (CD117) expression in differentiating adenoid cystic carcinoma and polymorphous low grade Adenocarcinoma.
Tariq H; Anjum S; Din HU; Akhtar F
Pak J Med Sci; 2017; 33(6):1376-1380. PubMed ID: 29492062
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of c-kit protein (CD117) expression in common salivary gland neoplasms.
Salehinejad J; Mohtasham N; Bagherpour A; Abbaszadeh-Bidokhty H; Ghazi A
J Oral Maxillofac Pathol; 2014 May; 18(2):177-82. PubMed ID: 25328295
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a primary and a metastatic melanoma cell line from Grey horses.
Seltenhammer MH; Sundström E; Meisslitzer-Ruppitsch C; Cejka P; Kosiuk J; Neumüller J; Almeder M; Majdic O; Steinberger P; Losert UM; Stöckl J; Andersson L; Sölkner J; Vetterlein M; Golovko A
In Vitro Cell Dev Biol Anim; 2014 Jan; 50(1):56-65. PubMed ID: 23982913
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of c-kit and CD43 in histological subtypes of adenoid cystic carcinoma of salivary gland.
Ahmed MM; Abo-Hager EA
Saudi Dent J; 2010 Jan; 22(1):27-34. PubMed ID: 23960476
[TBL] [Abstract][Full Text] [Related]
8. Driver mutations in melanoma: lessons learned from bench-to-bedside studies.
Mehnert JM; Kluger HM
Curr Oncol Rep; 2012 Oct; 14(5):449-57. PubMed ID: 22723080
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.
Murali R; Goumas C; Kricker A; From L; Busam KJ; Begg CB; Dwyer T; Gruber SB; Kanetsky PA; Orlow I; Rosso S; Thomas NE; Berwick M; Scolyer RA; Armstrong BK;
Ann Surg Oncol; 2012 Mar; 19(3):1024-33. PubMed ID: 21913010
[TBL] [Abstract][Full Text] [Related]
11. Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications.
Bell D; Roberts D; Kies M; Rao P; Weber RS; El-Naggar AK
Cancer; 2010 Dec; 116(24):5749-56. PubMed ID: 20824717
[TBL] [Abstract][Full Text] [Related]
12. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.
Torres-Cabala CA; Wang WL; Trent J; Yang D; Chen S; Galbincea J; Kim KB; Woodman S; Davies M; Plaza JA; Nash JW; Prieto VG; Lazar AJ; Ivan D
Mod Pathol; 2009 Nov; 22(11):1446-56. PubMed ID: 19718013
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.
Orlow I; Tommasi DV; Bloom B; Ostrovnaya I; Cotignola J; Mujumdar U; Busam KJ; Jungbluth AA; Scolyer RA; Thompson JF; Armstrong BK; Berwick M; Thomas NE; Begg CB
J Invest Dermatol; 2009 Aug; 129(8):1972-82. PubMed ID: 19282844
[TBL] [Abstract][Full Text] [Related]
14. The role of c-kit and imatinib mesylate in uveal melanoma.
Pereira PR; Odashiro AN; Marshall JC; Correa ZM; Belfort R; Burnier MN
J Carcinog; 2005 Oct; 4():19. PubMed ID: 16236162
[TBL] [Abstract][Full Text] [Related]
15. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes.
Guerriere-Kovach PM; Hunt EL; Patterson JW; Glembocki DJ; English JC; Wick MR
Am J Clin Pathol; 2004 Jul; 122(1):70-7. PubMed ID: 15272532
[TBL] [Abstract][Full Text] [Related]
16. bcl-2 protein expression in melanocytic neoplasms of the skin.
Ramsay JA; From L; Kahn HJ
Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
[TBL] [Abstract][Full Text] [Related]
17. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
Nazarian RM; Prieto VG; Elder DE; Duncan LM
J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
Isabel Zhu Y; Fitzpatrick JE
J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
